Targeted CRISPR-Cas9 screening identifies core transcription factors controlling murine haemato-endothelial fate

Michael Teske1,2, Tobias Wertheimer1,3, Stefan Butz2

  • 1Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.

Nature Communications
|December 13, 2025
PubMed